Imagion Biosystems Limited (ASX:IBX) (the Company), a Company dedicated to improving healthcare through the earlier detection of cancer, is pleased to share the updated investor presentation.
Chief Executive Officer Robert (Bob) Proulx is conducting an investor roadshow in Sydney, Melbourne and Perth from Monday 9 – Friday 13 September, 2019.
Download the investor presentation.
Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway
September 9, 2025
Highlights Dr Nina Webster appointed as IBX Non-Executive Director, bringing significant clinical development expertise and corporate experienceto the IBX Board ahead of HER2 Breast cancer